Global Meperidine(Demerol) Market, by Dosage Form (Tablets, Injection, and Syrup), byDistribution Channel (Hospital Pharmacies, Retail Pharmacies, and OnlinePharmacies), and by Region (North America, Latin America, Europe, Asia Pacific,Middle East, and Africa) is estimated to be valued at US$ 2,089.1 Mn in 2020 andis expected to increase to US$ 2,784.3 Mn by 2027, witnessing a CAGR of 4.2%during the forecast period (2020-2027) as highlighted in a new report publishedby Coherent Market Insights.
Manufacturers are engaged indeveloping new meperidine (Demerol) products for pain management, which has ledto an increase in product launches and approvals. This is expected to boost theglobal meperidine (Demerol) market growth. For instance, in 2015, Epic Pharma,launched generic meperidine in the U.S. for the relief of moderate to severepain in 50-mg and 100-mg dosage strengths in 100 count bottles. Moreover,manufacturers such as Pfizer, Inc., Hikma Pharmaceuticals, and others alsooffer branded as well as generic meperidine in the market.
Browse 24 Market Data Tables, and26 Figures spread through 140 Pages and in-depth TOC on Global Meperidine(Demerol) Market, by Dosage Form (Tablets, Injection, and Syrup), byDistribution Channel (Hospital Pharmacies, Retail Pharmacies, and OnlinePharmacies), and by Region (North America, Latin America, Europe, Asia Pacific,Middle East, and Africa) - Global Forecast to 2027
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/3816
The rising prevalence of chronicdiseases such as cancer and pain associated diseases is expected to result inhigher use of potent opioid medications for pain management. Moreover,meperidine is used as a drug for post-operative pain. Meperidine has advantagessuch as providing very short analgesia which is appropriate for minimallyinvasive surgeries. Moreover, the growing preference for minimally invasivesurgeries is also expected to support growth of the market during the forecastperiod. For instance, according a study published in January 2020 in JamaNetwork (The Journal of the American Medical Association), the use of roboticsurgeries for all procedures had increased from 1.8% to 15.1% from 2012 to 2018in the U.S. These factors are expected to support global meperidine (Demerol)market growth during the forecast period.
The increasing number of surgicalprocedures are expected to drive the global meperidine (Demerol) market growth
Opioids such as meperidine areused as pre-anesthetic medication in the surgical procedure, and are also usedas part of anesthesia to prevent pain after surgical procedure. Opioids arealso used in surgical treatment related to cancer. They are also used incardiovascular procedures to obtain the relief from post-surgical treatmentpain. The increasing number of surgeries worldwide is expected to supportgrowth of the market during the forecast period. For instance, according to Eurostat,2019, there were at least 1.4 million caesarean sections performed in the EU in2017. Moreover, pain management related to cancer disease, back pain,neuropathic pain, migraine, osteoarthritis, and pain which occurs after thesurgical procedures also involves use of opioids such as meperidine. The risingprevalence of such diseases is expected to support global meperidine (Demerol)market growth during the forecast period.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/meperidine-market-3816
Key takeaways of the globalmeperidine (Demerol) market:
The global meperidine (Demerol)market is expected to exhibit a CAGR of 4.2% during the forecast period(2020-2027) owing to product approvals and launches as well as increasingprevalence of chronic diseases requiring surgical intervention.
On the basis of dosage form, theinjection segment is expected to hold a dominant position in the globalmeperidine (Demerol) market during the forecast period owing to high use inpost-operative pain management and post pregnancy pain management.
Based on distribution channel,the hospital pharmacies segment is expected to witness significant growth dueto increasing use of meperidine in post-operative pain management as it wouldbe sold through hospital pharmacies.
Some of the major playersinvolved in the global meperidine (Demerol) market are Pfizer, Inc., HikmaPharmaceuticals USA Inc., Epic Pharma, Inc., and Vintage Pharmaceuticals, Inc.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/3816
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
